Atrial Fibrillation Non-Rheumatic

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Atrial Fibrillation Non-Rheumatic trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05021601

Bi-atrial Versus Left Atrial Ablation for Patients With Rheumatic Mitral Valve Disease and Non-paroxysmal Atrial Fibrill…

This study is aimed to compare the efficacy of bi-atrial ablation with left atrial ablation for atrial fibrillation during mitral valve surgery in patients with…

China320 participantsStarted 2022-05-10

Treatment: Bi-atrial ablation, Left atrial ablation

All recent trials (4 shown)

UnknownPhase 3

NCT03777631

STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STAB…

Catheter ablation (CA) has been reported to reduce risk of stroke in patients with nonvalvular atrial fibrillation (NVAF) in retrospective studies, but risk and…

Japan251 participantsStarted 2018-04-01

Treatment: Catheter ablation

CompletedPhase 3

NCT02832544

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority

This program is a comprehensive evaluation of rheumatic valvular heart disease (RVHD), Atrial fibrillation (AF)/flutter and stroke. A prospective, randomized,…

Botswana, Brazil4,565 participantsStarted 2016-08-22

Treatment: Rivaroxaban (20 mg), Vitamin K antagonists (VKA)

Atrial Fibrillation Non-Rheumatic

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Bi-atrial Versus Left Atrial Ablation for Patients With Rheumatic Mitral Valve Disease and Non-paroxysmal Atrial Fibrill…

All recent trials (4 shown)

STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STAB…

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Bi-atrial Versus Left Atrial Ablation for Patients With Rheumatic Mitral Valve Disease and Non-paroxysmal Atrial Fibrill…

All recent trials (4 shown)

STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STAB…

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority

A Study to Evaluate the Safety and Effectiveness of the Left Atrial Appendage Closure Therapy Using BSJ003W